RU95107652A - Алкилированные аминоалканимидазолы и триазолы, способ их получения и содержащий их фармацевтический состав - Google Patents
Алкилированные аминоалканимидазолы и триазолы, способ их получения и содержащий их фармацевтический составInfo
- Publication number
- RU95107652A RU95107652A RU95107652/04A RU95107652A RU95107652A RU 95107652 A RU95107652 A RU 95107652A RU 95107652/04 A RU95107652/04 A RU 95107652/04A RU 95107652 A RU95107652 A RU 95107652A RU 95107652 A RU95107652 A RU 95107652A
- Authority
- RU
- Russia
- Prior art keywords
- compounds
- aminoalkaneimidazoles
- triazoles
- acylated
- preparing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008196 pharmacological composition Substances 0.000 title 1
- 150000003852 triazoles Chemical class 0.000 title 1
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 claims abstract 2
- JWUBBDSIWDLEOM-DCHLRESJSA-N 25-Hydroxyvitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C/C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DCHLRESJSA-N 0.000 claims abstract 2
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 claims abstract 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims abstract 2
- 229940124639 Selective inhibitor Drugs 0.000 claims abstract 2
- 229930003316 Vitamin D Natural products 0.000 claims abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract 2
- 150000003851 azoles Chemical class 0.000 claims abstract 2
- 230000001419 dependent effect Effects 0.000 claims abstract 2
- 230000004069 differentiation Effects 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 125000002971 oxazolyl group Chemical group 0.000 claims abstract 2
- 230000035755 proliferation Effects 0.000 claims abstract 2
- 150000003839 salts Chemical group 0.000 claims abstract 2
- 125000001424 substituent group Chemical group 0.000 claims abstract 2
- 235000019166 vitamin D Nutrition 0.000 claims abstract 2
- 239000011710 vitamin D Substances 0.000 claims abstract 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract 2
- 229940046008 vitamin d Drugs 0.000 claims abstract 2
- 102000008109 Mixed Function Oxygenases Human genes 0.000 abstract 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 abstract 1
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Lubricants (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Изобретение предусматривает азольные соединения, отвечающие формуле Iв которой указанные заместители имеют различное значение, находящиеся в свободной форме или в форме соли. Указанные соединения могут быть получены, например, путем ацилирования или раскрытия азиридинового или оксазольного кольца, их можно использовать в качестве фармацевтических средств, особенно в качестве избирательных ингибиторов 25-гидроксивитамина D3 при лечении заболеваний, связанных с пролиферацией и дифференцировкой тканей, зависимых от витамина D.
Claims (1)
- Изобретение предусматривает азольные соединения, отвечающие формуле I
в которой указанные заместители имеют различное значение, находящиеся в свободной форме или в форме соли. Указанные соединения могут быть получены, например, путем ацилирования или раскрытия азиридинового или оксазольного кольца, их можно использовать в качестве фармацевтических средств, особенно в качестве избирательных ингибиторов 25-гидроксивитамина D3 при лечении заболеваний, связанных с пролиферацией и дифференцировкой тканей, зависимых от витамина D.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9409882A GB9409882D0 (en) | 1994-05-18 | 1994-05-18 | Organic compounds |
| GB9409882.9 | 1994-05-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU95107652A true RU95107652A (ru) | 1997-03-20 |
| RU2152933C2 RU2152933C2 (ru) | 2000-07-20 |
Family
ID=10755289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU95107652/04A RU2152933C2 (ru) | 1994-05-18 | 1995-05-16 | Ацилированные аминоалкилимидазолы, способ их получения и фармацевтическая композиция |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5622982A (ru) |
| EP (1) | EP0683156B1 (ru) |
| JP (1) | JP2912566B2 (ru) |
| KR (1) | KR100371465B1 (ru) |
| CN (1) | CN1060163C (ru) |
| AT (1) | ATE164576T1 (ru) |
| AU (1) | AU696880B2 (ru) |
| BR (1) | BR9502062A (ru) |
| CA (1) | CA2149459C (ru) |
| CO (1) | CO4290423A1 (ru) |
| CZ (1) | CZ285385B6 (ru) |
| DE (1) | DE69501915T2 (ru) |
| DK (1) | DK0683156T3 (ru) |
| ES (1) | ES2114289T3 (ru) |
| FI (1) | FI112364B (ru) |
| GB (1) | GB9409882D0 (ru) |
| GR (1) | GR3026505T3 (ru) |
| HU (1) | HUT72063A (ru) |
| IL (1) | IL113743A (ru) |
| MY (1) | MY135559A (ru) |
| NO (1) | NO304738B1 (ru) |
| NZ (1) | NZ272129A (ru) |
| PE (1) | PE14896A1 (ru) |
| PH (1) | PH31510A (ru) |
| RU (1) | RU2152933C2 (ru) |
| SI (1) | SI0683156T1 (ru) |
| SK (1) | SK280326B6 (ru) |
| TW (1) | TW351718B (ru) |
| ZA (1) | ZA954074B (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869499A (en) * | 1993-07-15 | 1999-02-09 | Pfizer Inc | Benzyloxyquinuclidines as substance P antagonists |
| EP0862916B1 (en) * | 1995-11-20 | 2003-03-05 | Kiyoshi Kita | topical use of vitamin D for the treatment of eye disorders |
| AU2792997A (en) * | 1997-05-26 | 1998-12-30 | New Vision Co., Ltd. | Medicinal compositions for topical administration containing vitamin d and vitamin k |
| US6034251A (en) * | 1997-11-07 | 2000-03-07 | Schering Corporation | Phenyl-alkyl-imidazoles |
| TW575562B (en) * | 1998-02-19 | 2004-02-11 | Agrevo Uk Ltd | Fungicides |
| CN1114593C (zh) * | 1998-05-08 | 2003-07-16 | 陶氏益农有限责任公司 | 2位被取代的吡啶的制备 |
| GB0029524D0 (en) * | 2000-12-04 | 2001-01-17 | Univ Sheffield | Disease treatment |
| GB0128415D0 (en) * | 2001-11-27 | 2002-01-16 | Univ Sheffield | Medicaments |
| JP2004196795A (ja) * | 2002-12-16 | 2004-07-15 | Wyeth | 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル |
| US7429604B2 (en) * | 2004-06-15 | 2008-09-30 | Bristol Myers Squibb Company | Six-membered heterocycles useful as serine protease inhibitors |
| WO2006032299A1 (en) * | 2004-09-24 | 2006-03-30 | Susanna Miettinen | Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| WO2006036892A2 (en) * | 2004-09-24 | 2006-04-06 | Sapphire Therapeutics, Inc. | Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| CN104530038A (zh) * | 2014-12-10 | 2015-04-22 | 沈阳药科大学 | 酰胺咪唑类衍生物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2041771C3 (de) * | 1970-08-22 | 1979-07-26 | Bayer Ag, 5090 Leverkusen | derivate |
| US4191767A (en) * | 1977-01-07 | 1980-03-04 | Westwood Pharmaceuticals, Inc. | Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines |
| IT1097314B (it) * | 1978-07-26 | 1985-08-31 | Recordati Chem Pharm | Derivati dell'imidazolo ad attivita' anticonvulsivante |
| CH655103A5 (de) * | 1983-03-11 | 1986-03-27 | Sandoz Ag | Azolderivate, verfahren zu ihrer herstellung und ihre verwendung. |
| CH677925A5 (ru) * | 1986-12-03 | 1991-07-15 | Sandoz Ag | |
| DE3644616A1 (de) * | 1986-12-29 | 1988-07-07 | Lentia Gmbh | Imidazolderivate, verfahren zur herstellung und deren verwendung |
| IT1237792B (it) * | 1989-12-21 | 1993-06-17 | Zambon Spa | Composti attivi come inibitori dell'enzima hmg-coa reduttasi |
-
1994
- 1994-05-18 GB GB9409882A patent/GB9409882D0/en active Pending
-
1995
- 1995-05-16 CA CA002149459A patent/CA2149459C/en not_active Expired - Fee Related
- 1995-05-16 SI SI9530063T patent/SI0683156T1/xx not_active IP Right Cessation
- 1995-05-16 DE DE69501915T patent/DE69501915T2/de not_active Expired - Lifetime
- 1995-05-16 AU AU20089/95A patent/AU696880B2/en not_active Ceased
- 1995-05-16 NO NO951944A patent/NO304738B1/no not_active IP Right Cessation
- 1995-05-16 SK SK635-95A patent/SK280326B6/sk not_active IP Right Cessation
- 1995-05-16 RU RU95107652/04A patent/RU2152933C2/ru not_active IP Right Cessation
- 1995-05-16 IL IL11374395A patent/IL113743A/xx not_active IP Right Cessation
- 1995-05-16 US US08/442,053 patent/US5622982A/en not_active Expired - Lifetime
- 1995-05-16 DK DK95810325T patent/DK0683156T3/da active
- 1995-05-16 CZ CZ951265A patent/CZ285385B6/cs not_active IP Right Cessation
- 1995-05-16 NZ NZ272129A patent/NZ272129A/en not_active IP Right Cessation
- 1995-05-16 ES ES95810325T patent/ES2114289T3/es not_active Expired - Lifetime
- 1995-05-16 AT AT95810325T patent/ATE164576T1/de not_active IP Right Cessation
- 1995-05-16 MY MYPI95001281A patent/MY135559A/en unknown
- 1995-05-16 PE PE1995268750A patent/PE14896A1/es not_active Application Discontinuation
- 1995-05-16 FI FI952383A patent/FI112364B/fi active
- 1995-05-16 EP EP95810325A patent/EP0683156B1/en not_active Expired - Lifetime
- 1995-05-17 BR BR9502062A patent/BR9502062A/pt not_active IP Right Cessation
- 1995-05-17 CN CN95106034A patent/CN1060163C/zh not_active Expired - Fee Related
- 1995-05-17 CO CO95021039A patent/CO4290423A1/es unknown
- 1995-05-17 KR KR1019950012172A patent/KR100371465B1/ko not_active Expired - Fee Related
- 1995-05-17 JP JP7118345A patent/JP2912566B2/ja not_active Expired - Fee Related
- 1995-05-17 HU HU9501451A patent/HUT72063A/hu not_active Application Discontinuation
- 1995-05-17 PH PH50532A patent/PH31510A/en unknown
- 1995-05-18 ZA ZA954074A patent/ZA954074B/xx unknown
- 1995-05-19 TW TW084105010A patent/TW351718B/zh not_active IP Right Cessation
-
1998
- 1998-04-03 GR GR980400688T patent/GR3026505T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU95107652A (ru) | Алкилированные аминоалканимидазолы и триазолы, способ их получения и содержащий их фармацевтический состав | |
| MX9702380A (es) | Nuevas carboxamidas con actividad antifungica. | |
| IL110031A0 (en) | Phenyl heterocycles, their manufacture and pharmaceutical compositions containing them | |
| RU94042922A (ru) | Новые соединения, способы их получения, фармацевтическая композиция | |
| CY1112084T1 (el) | Παραγωγα 5-φαινυλθειαζολης και χρηση ως αναστολεις της κινασης ρi3 | |
| SE9902987D0 (sv) | Novel compounds | |
| ATE337316T1 (de) | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen | |
| HU913193D0 (en) | 17betha-substituted 4-aza-5alpha-androstane-3-on derivatives, process for their production and for the production of medical preparations containing them | |
| FI913478A0 (fi) | Diazinderivat. | |
| ATE364043T1 (de) | Pyrazolo-pyridine für die behandlung von herpes- ansteckungen | |
| HUT77627A (hu) | 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények | |
| SE7611103L (sv) | Forfarande for framstellning av 2-azetidinonforeningar | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| EP0137440A3 (de) | Cephalosporinderivate und Verfahren zu ihrer Herstellung | |
| EP0137441A3 (de) | Cephalosporinderivate und Verfahren zu ihrer Herstellung | |
| DE602004021363D1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| RU94046300A (ru) | Химические соединения, способ их получения, фармкомпозиция, способ лечения, промежуточный продукт | |
| ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
| RU95109874A (ru) | Гетероциклилоксибензоилгуанидины, способ их получения, содержащая их фармацевтическая композиция и способ ее получения | |
| EP0379132A3 (de) | Cephalosporinderivate und Verfahren zu ihrer Herstellung | |
| RU95102147A (ru) | Производные 1-[2-(1н-инден-3-ил)этил]-4-(нафт-1-ил)пиперазина, способ их получения и содержащие их медикамент и фармацевтический состав | |
| RU94033096A (ru) | Соединение, способ лечения и фармацевтическая композиция | |
| RU95107706A (ru) | Пиридоиндолобензодиазепины и их производные, фармацевтическая композиция антипсихоточеского действия на их основе и способ лечения | |
| EP0281092A3 (de) | Cephalosporinderivate und Verfahren zu ihrer Herstellung | |
| EP0390066A3 (de) | Cephalosporinderivate und Verfahren zu ihrer Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110517 |